WO1997032031A1 - Bioconversion stereospecifique du benzylacetoacetate en benzyl-(s)-(+)-3-hydroxybutyrate - Google Patents
Bioconversion stereospecifique du benzylacetoacetate en benzyl-(s)-(+)-3-hydroxybutyrate Download PDFInfo
- Publication number
- WO1997032031A1 WO1997032031A1 PCT/US1997/002876 US9702876W WO9732031A1 WO 1997032031 A1 WO1997032031 A1 WO 1997032031A1 US 9702876 W US9702876 W US 9702876W WO 9732031 A1 WO9732031 A1 WO 9732031A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- benzyl
- hydroxybutyrate
- acetoacetate
- bioconversion
- medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
Definitions
- a bioconversion process employing Candida schatavii strain MY 1831 is presented.
- benzyl cetoacetate is converted to benzyl-(S)-(+)-3-hydroxybutyrate.
- a bioconversion process employing Candida schatavii strain MY 1831 is presented.
- benzyl acetoacetate is converted to benzyl-(S)-(+)-3-hydroxybutyrate.
- a bioconversion process employing Candida schatavii strain MY 1831 is presented.
- benzyl acetoacetate is converted to benzyl-(S)-(+)-3-hydroxybutyrate.
- the present invention is directed to a fermentation process which employs a readily prepared culture medium.
- Culture medium as used herein is defined as a mixture which supports the growth of yeast cells, which mixture contains ingredients such as peptone, soy peptone, and yeast extract powder. It should be understood that the precise amounts of ingredients provided above may be optimized, or modified so long as no new components are introduced.
- the key aspect of the medium is its ability to support growth of Candida schatavii and thereby the production of benzyl-(S)-(+)-3-hydroxybutyrate by bioreduction of benzyl acetoacetate.
- the product compounds may be produced by culturing (fermenting) the above-described microorganism in the presence of an appropriate amount of benzyl acetoacetate substrate in an aqueous nutrient medium containing sources of assimilable carbon and nitrogen, preferably under submerged aerobic conditions (e.g. shaking culture, submerged culture, etc.).
- the aqueous medium is incubated at a temperature between 26°C and 29°C, preferably 28°C.
- the aqueous medium is incubated for a period of time necessary to complete the biotransformation as monitored by HPLC, usually for a period of about 24-48 hours, on a rotary shaker operating at about 220 rpm with a throw of about 2 in.
- Submerged aerobic cultural conditions may be preferred for the production of product compounds in massive amounts.
- a shaking or surface culture in a flask or bottle is employed.
- a vegetative inoculum of the organism by inoculating a relatively small quantity of culture medium with cells produced in a "slant” and culturing said inoculated medium, also called the “seed medium”, and then to transfer the cultured vegetative inoculum aseptically to large tanks.
- the fermentation medium, in which the inoculum is produced is substantially the same as or different from the medium utilized for the production of product compounds and is generally autoclaved to sterilize the medium prior to inoculation.
- Agitation and aeration of the culture mixture may be accomplished in a variety of ways. Agitation may be provided by a propeller or similar mechanical agitation equipment, by revolving or shaking the fermentation flask, by various pumping equipment or by the passage of sterile air through the medium. Aeration may be effected by passing sterile air through the fermentation mixture.
- the fermentation is usually conducted at a temperature between 20°C and 35°C, for a period of about 24 hours to 48 hours, which may be varied according to fermentation conditions and scales.
- the production cultures are incubated for about 48 hours at 28°C on a rotary shaker operating at 220 rpm.
- Preferred culturing/production media for carrying out the fermentation include the Sabouraud Dextrose medium (30 g/L; Difco).
- the biotransformation product may be recovered from the culture medium by conventional means which are commonly used for the recovery of other known biologically active substances.
- the product compounds are found filtrate, which are obtained by filtering or centrifuging the cultured broth, and accordingly can be isolated and purified by a conventional method such as concentration under reduced pressure, lyophilization, extraction with a conventional solvent, such as ethylacetate and the like, pH adjustment, treatment with a conventional resin (e.g. anion or cation exchange resin, non-ionic adsorption resin, etc.), treatment with a conventional adsorbent (e.g. activated charcoal, silicic acid, silica gel, cellulose, alumina, etc.), crystallization, recrystallization, and the like.
- a preferred recovery method is solvent extraction, particularly using ethylacetate.
- the compounds of the present invention have the following structures.
- Compound (I) benzyl acetoacetate is the starting material.
- Compound (II) is the product, benzyl-(S)-(+)-3-hydroxybutyrate.
- the substrate, benzyl acetoacetate may be prepared via a synthetic process or may be purchased commercially.
- a chemical reference for desired product was prepared as follows. Methyl (S)-(+)-3-hydroxybutyrate (Aldrich) was dissolved in benzyl alcohol and treated with a catalytic amount of titanium tetraisopropoxide. The mixture was aged at 60 Q C for 24 hours. Partial concentration on a rotary evaporator and filtration afforded benzyl (S)- (+)-3-hydroxybutyrate and residual benzyl alcohol.
- Methyl (S)-(+)-3-hydroxybutyrate Aldrich
- the enantiomers were separated using a Chiralcel OD column (Chiral Technologies), employing a mobile phase comprised of a mixture of 98 % hexane and 2 % isopropanol at a flow rate of 0.6 ml/min.
- Yeast cells were preserved on slants of Sabouraud dextrose agar (Difco) kept at 4°C. Cells were obtained from the slants using a sterile loop and used to inoculate a 250-ml Erlenmeyer flask containing 50-ml of Sabouraud dextrose broth. The cultures were incubated aerobically at 28 e C for 48 hours on a shaker operated at 220 rpm. A volume of 2.5 ml of this 48 h-old culture was used to inoculate a 250-ml Erlenmeyer flask containing 50 ml of Sabouraud dextrose medium. The cultures were incubated in the same conditions as described above for 24 hours.
- the substrate for bioconversion (benzyl acetoacetate) was added to each flask in 1 ml of ethanol to give a final concentration of 1 g/1.
- the cultures were incubated for 24 hours under the same conditions.
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
L'invention porte sur un procédé de bioconversion du benzylacétoacétate en benzyl-(S)-(+)-3-hydroxybutyrate.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1269296P | 1996-03-01 | 1996-03-01 | |
| US60/012,692 | 1996-03-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1997032031A1 true WO1997032031A1 (fr) | 1997-09-04 |
Family
ID=21756238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1997/002876 Ceased WO1997032031A1 (fr) | 1996-03-01 | 1997-02-25 | Bioconversion stereospecifique du benzylacetoacetate en benzyl-(s)-(+)-3-hydroxybutyrate |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO1997032031A1 (fr) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4933282A (en) * | 1985-11-28 | 1990-06-12 | Nippon Gohsei Kagaku Kogyo Kabushiki Kaisha | Process for preparing an optically active γ-halo-β-hydroxybutyric acid ester |
-
1997
- 1997-02-25 WO PCT/US1997/002876 patent/WO1997032031A1/fr not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4933282A (en) * | 1985-11-28 | 1990-06-12 | Nippon Gohsei Kagaku Kogyo Kabushiki Kaisha | Process for preparing an optically active γ-halo-β-hydroxybutyric acid ester |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1111605C (zh) | 发酵生产维生素b6 | |
| US5407826A (en) | Isolated cultures of microorganisms of Clonostachys Cylindrospora, Gliocladium and Nectria Gliocladioides | |
| CA2116003C (fr) | Isolation d'un acide arylalcanoique | |
| US5958743A (en) | Stereospecific bioconversion of benzyl acetoacetate to benzyl-(s)-(+)-hydroxybutyrate | |
| US7141412B2 (en) | Process for preparing optically active 3-hydroxypyrrolidine derivatives by enzymatic hydroxylation | |
| CA1109406A (fr) | Production de monorden | |
| WO1997032031A1 (fr) | Bioconversion stereospecifique du benzylacetoacetate en benzyl-(s)-(+)-3-hydroxybutyrate | |
| EP0434393A2 (fr) | Procédé de préparation de R-(-)-3-halogéno-1,2-propanediol par un traitement de microorganismes | |
| US6451587B1 (en) | Microbial asymmetric reduction of 2-chloro-1-[-6-(2,5-dimethyl-pyrrol-1-yl)-pyridin-3-yl]-ethanone | |
| JP3023179B2 (ja) | 立体選択的微生物還元プロセス | |
| US5232853A (en) | Method for producing (2r,3s)-3-hydroxy-2-methylbutyrate by microbial reduction | |
| Chartrain et al. | Asymmetric bioreduction of benzyl acetoacetate to its corresponding alcohol, benzyl (S)-(+)-3-hydroxybutyrate by the yeast Candida schatavii MY 1831 | |
| EP0481712B1 (fr) | Procédé de préparation d'acide méthylsuccinique optiquement actif | |
| JP2693536B2 (ja) | （７Ｒ）―シクロペンタ〔ｄ〕ピリミジン誘導体の製造法 | |
| EP1325146B1 (fr) | Procede de preparation de 4-hydroxy-2-pyrrolidinone et de 4-hydroxy-2-pyrrolidinones n-substituees optiquement actives par hydroxylation enzymatique | |
| AU620595B2 (en) | Process for the preparation of macrolide compounds | |
| HK1038768A1 (zh) | 制备旋光的3-羟基吡咯烷衍生物的微生物法 | |
| JPH0592967A (ja) | １０員環ラクトン構造を有する新規な天然物質 | |
| Matzinger et al. | Asymmetric microbial reduction of ethyl and isoprophyl α, 1, 3-trioxo-2-isoindolinebutyrate | |
| JPH04166093A (ja) | 微生物を利用した光学活性ベンゾヒドロール誘導体の製造方法 | |
| JPH0539B2 (fr) | ||
| JPH01199582A (ja) | 新規抗生物質ｆｏ−１２５ａ↓４、ａ↓５、ｂおよびそれらの製造法 | |
| JP2003093046A (ja) | 有用変換微生物 | |
| JP2003125793A (ja) | 光学活性１，２−トランス−シクロヘキサンジオールの製造方法 | |
| HK1010740B (en) | Microbial process for the production of trans-4-hydroxyl-l-proline |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA JP US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 97531054 Format of ref document f/p: F |
|
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: CA |